Cargando…
Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity
Weight loss can reduce the increased cardiovascular risk associated with obesity. Pharmacotherapy is a recognized weight loss treatment option; however, cardiovascular safety issues with some previous weight loss drugs raise concerns for newly approved pharmacotherapies. Phentermine is approved for...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011567/ https://www.ncbi.nlm.nih.gov/pubmed/24621808 http://dx.doi.org/10.1097/HJH.0000000000000145 |